Clinical Trial Update: Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating Yiqi Wenyang Jiedu Prescription for prevention and treatment of postoperative metastasis and recurrence in gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Carcinoma

Drugs mentioned

• Yiqi Wenyang Jiedu Prescription

Snippet

Sponsor: Jie Li | Conditions: Gastric Carcinoma | Phase 4 | Status: UNKNOWN